ArticleCancer causes & control : CCC2026
Emergency diagnosis of multiple myeloma: a SEER-Medicare study.
Article in Cancer causes & control : CCC, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
purposeNon-specific presenting symptoms make multiple myeloma (MM) one of the most difficult hematologic cancers to diagnose, increasing the risk of late diagnosis and emergency presentation (EP). We examined the frequency of EP in MM, estimated associations between EP and patient-level factors, and MM symptom-related healthcare utilization in the year before diagnosis.
methodsWe studied Medicare beneficiaries age ≥ 66 years diagnosed with MM between 2008 and 2017. Emergency presentation (EP) was defined as diagnosis preceded by a recent ED visit, sub-classified as: inpatients (EP-IP) for subsequently admitted patients and outpatients (EP-OP) for those discharged for follow-up care.
resultsAmong 20,437 patients, 52% were male, 75% non-Hispanic White (NHW), and the median age was 76. Overall, 37% were diagnosed through involvement with the ED (EP-IP: 30%; EP-OP: 7%). In iteratively adjusted models, oldest age, female sex, non-Hispanic Black, Hispanic, Asian American, Native Hawaiian or Other Pacific Islander race and ethnicity, unmarried status, dual eligibility for Medicaid and Medicare, lowest county SES, rurality, frailty, and higher healthcare use in the year pre-diagnosis were associated with higher frequency of ED involvement in diagnosis. Symptom-related healthcare utilization was comparable among EP and non-EP groups in the year preceding MM diagnosis but markedly increased for the EP group in the month before diagnosis.
conclusionsMore than one-third of older US adults with MM are diagnosed through EP. Several socio-demographic, clinical and healthcare utilization factors are associated with EP. Similarities in healthcare utilization across EP status in the months preceding diagnosis suggest missed opportunities for earlier detection of MM.
Indexed as
Identifiers
42832123What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.